Drugs / influenza vaccine（BK01 adjuvnat）
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07349017 | Feb → Apr 2026 overdue | influenza | Changchun BCHT Biotechnology Co. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | influenza vaccine（BK01 adjuvnat） | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07349017 ↗ |
| Modality | Vaccine | “Influenza Virus Split Vaccine (Adjuvant)” NCT07349017 ↗ |